# STRIVE Post-Market Registry Study

> **NCT04302272** · — · RECRUITING · sponsor: **Olympus Corporation of the Americas** · enrollment: 150 (estimated)

## Conditions studied

- Emphysema

## Interventions

- **DEVICE:** Spiration Valve System (SVS)

## Key facts

- **NCT ID:** NCT04302272
- **Lead sponsor:** Olympus Corporation of the Americas
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-09
- **Primary completion:** 2026-12
- **Final completion:** 2029-10
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04302272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04302272, "STRIVE Post-Market Registry Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04302272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*